Strategic partnership Bayer collaboration to launch LASS program with BlinkRx signals strong potential for co-branded, payer-supported initiatives that expand access to branded medications, creating cross-sell opportunities with large pharma.

Affordability focus BlinkRx emphasizes transparent low prices and affordable monthly options (as low as $25) which can be leveraged to pitch to other payers, employers, and health systems seeking cost containment and improved medication adherence.

Large market potential Revenue range in the hundreds of millions and a sizable client base position BlinkRx as a scalable platform for hospitals, health systems, and pharmaceutical partners aiming to digitize patient access and home delivery.

Digital concierge The centralized cloud platform with a digital concierge, home delivery, and patient support offers upsell opportunities for value-added services such as adherence programs, tele-support, and prior authorization workflow optimization.

Tech-enabled growth Advanced tech stack including ML tooling, cloud infrastructure, and AI capabilities enables data-driven sales pitches to enterprise buyers focused on improved outcomes, stock visibility, and patient experience enhancements.